Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human IL-19 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 1035IL025
This item is not returnable.
View return policy
Description
The Recombinant Human IL-19 Protein is derived from E. coli. The Recombinant Human IL-19 Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
18 kDa (monomer) | |
25 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant | |
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
29949 | |
IL-19 | |
E. coli-derived human IL-19 protein Leu25-Ala177,with an N-terminal Met | |
Unconjugated | |
Reconstitute at 100μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Product Content Correction